Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / COM
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
3,892,811
-
Shares change
-
-303,504
-
Total reported value, excl. options
-
$21,760,875
-
Value change
-
-$1,628,197
-
Number of buys
-
20
-
Number of sells
-
-12
-
Price
-
$5.59
Significant Holders of BIND THERAPEUTICS INC - COM (BINDQ) as of Q2 2015
41 filings reported holding BINDQ - BIND THERAPEUTICS INC - COM as of Q2 2015.
BIND THERAPEUTICS INC - COM (BINDQ) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3,892,811 shares
.
Largest 10 shareholders include Polaris Venture Management Co. V, L.L.C. (2,018,253 shares), VANGUARD GROUP INC (451,982 shares), RENAISSANCE TECHNOLOGIES LLC (359,400 shares), PRINCIPAL FINANCIAL GROUP INC (323,600 shares), Rhenman & Partners Asset Management AB (133,535 shares), BlackRock Advisors LLC (104,395 shares), CREDIT SUISSE AG/ (80,811 shares), GEODE CAPITAL MANAGEMENT, LLC (51,023 shares), STIFEL FINANCIAL CORP (40,934 shares), and BRIDGEWAY CAPITAL MANAGEMENT INC (35,000 shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.